AR022047A1 - Nuevos derivados de acidos carboxilicos con heterociclos de nitrogeno aril-sustituidos, su preparacion y utilizacion como antagonistas de los receptores deendotelina - Google Patents
Nuevos derivados de acidos carboxilicos con heterociclos de nitrogeno aril-sustituidos, su preparacion y utilizacion como antagonistas de los receptores deendotelinaInfo
- Publication number
- AR022047A1 AR022047A1 ARP000102660A ARP000102660A AR022047A1 AR 022047 A1 AR022047 A1 AR 022047A1 AR P000102660 A ARP000102660 A AR P000102660A AR P000102660 A ARP000102660 A AR P000102660A AR 022047 A1 AR022047 A1 AR 022047A1
- Authority
- AR
- Argentina
- Prior art keywords
- endothelin
- alkyl
- receptors
- halogen atoms
- carry
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/30—Only oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19924892A DE19924892A1 (de) | 1999-06-01 | 1999-06-01 | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR022047A1 true AR022047A1 (es) | 2002-09-04 |
Family
ID=7909761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000102660A AR022047A1 (es) | 1999-06-01 | 2000-05-30 | Nuevos derivados de acidos carboxilicos con heterociclos de nitrogeno aril-sustituidos, su preparacion y utilizacion como antagonistas de los receptores deendotelina |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1181281A2 (hu) |
| JP (1) | JP2003500476A (hu) |
| KR (1) | KR20020006049A (hu) |
| CN (1) | CN1359376A (hu) |
| AR (1) | AR022047A1 (hu) |
| AU (1) | AU765345B2 (hu) |
| BG (1) | BG106154A (hu) |
| BR (1) | BR0011105A (hu) |
| CA (1) | CA2375666A1 (hu) |
| CZ (1) | CZ20014312A3 (hu) |
| DE (1) | DE19924892A1 (hu) |
| HK (1) | HK1047102A1 (hu) |
| HU (1) | HUP0201387A3 (hu) |
| IL (1) | IL146800A0 (hu) |
| MX (1) | MXPA01012284A (hu) |
| NO (1) | NO20015762L (hu) |
| PL (1) | PL355112A1 (hu) |
| SK (1) | SK17552001A3 (hu) |
| TR (1) | TR200103475T2 (hu) |
| WO (1) | WO2000073276A2 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120035196A1 (en) * | 2009-04-22 | 2012-02-09 | Kenji Negoro | Carboxylic acid compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199901416T2 (xx) * | 1996-12-18 | 1999-08-23 | Basf Aktiengesellschaft | Heterosiklik karbonikasit t�revleri. |
| DE19726146A1 (de) * | 1997-06-19 | 1998-12-24 | Basf Ag | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| BR9811631A (pt) * | 1997-09-04 | 2000-09-26 | Basf Ag | Derivado de ácido carboxìlico e uso do mesmo |
| DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| DE19809144A1 (de) * | 1998-03-04 | 1999-09-09 | Basf Ag | Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten |
| DE19836044A1 (de) * | 1998-08-10 | 2000-02-17 | Basf Ag | Neue Carbonsäurederivate, die Ketoseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
-
1999
- 1999-06-01 DE DE19924892A patent/DE19924892A1/de not_active Withdrawn
-
2000
- 2000-05-19 EP EP00938660A patent/EP1181281A2/de not_active Withdrawn
- 2000-05-19 CZ CZ20014312A patent/CZ20014312A3/cs unknown
- 2000-05-19 WO PCT/EP2000/004571 patent/WO2000073276A2/de not_active Application Discontinuation
- 2000-05-19 CA CA002375666A patent/CA2375666A1/en not_active Abandoned
- 2000-05-19 CN CN00809738A patent/CN1359376A/zh active Pending
- 2000-05-19 BR BR0011105-8A patent/BR0011105A/pt not_active IP Right Cessation
- 2000-05-19 MX MXPA01012284A patent/MXPA01012284A/es unknown
- 2000-05-19 PL PL00355112A patent/PL355112A1/xx not_active Application Discontinuation
- 2000-05-19 JP JP2000621342A patent/JP2003500476A/ja active Pending
- 2000-05-19 AU AU53959/00A patent/AU765345B2/en not_active Ceased
- 2000-05-19 IL IL14680000A patent/IL146800A0/xx unknown
- 2000-05-19 KR KR1020017015482A patent/KR20020006049A/ko not_active Application Discontinuation
- 2000-05-19 TR TR2001/03475T patent/TR200103475T2/xx unknown
- 2000-05-19 SK SK1755-2001A patent/SK17552001A3/sk unknown
- 2000-05-19 HU HU0201387A patent/HUP0201387A3/hu unknown
- 2000-05-30 AR ARP000102660A patent/AR022047A1/es unknown
-
2001
- 2001-11-26 NO NO20015762A patent/NO20015762L/no not_active Application Discontinuation
- 2001-11-27 BG BG106154A patent/BG106154A/xx unknown
-
2002
- 2002-11-29 HK HK02108677.1A patent/HK1047102A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL146800A0 (en) | 2002-07-25 |
| HK1047102A1 (zh) | 2003-02-07 |
| SK17552001A3 (sk) | 2002-08-06 |
| AU5395900A (en) | 2000-12-18 |
| EP1181281A2 (de) | 2002-02-27 |
| BR0011105A (pt) | 2002-03-05 |
| CA2375666A1 (en) | 2000-12-07 |
| MXPA01012284A (es) | 2002-07-30 |
| CN1359376A (zh) | 2002-07-17 |
| DE19924892A1 (de) | 2000-12-07 |
| HUP0201387A3 (en) | 2004-12-28 |
| NO20015762L (no) | 2001-12-13 |
| CZ20014312A3 (cs) | 2003-02-12 |
| WO2000073276A2 (de) | 2000-12-07 |
| WO2000073276A3 (de) | 2001-05-10 |
| TR200103475T2 (tr) | 2002-04-22 |
| JP2003500476A (ja) | 2003-01-07 |
| AU765345B2 (en) | 2003-09-18 |
| NO20015762D0 (no) | 2001-11-26 |
| HUP0201387A2 (en) | 2002-08-28 |
| PL355112A1 (en) | 2004-04-05 |
| KR20020006049A (ko) | 2002-01-18 |
| BG106154A (en) | 2002-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR035783A1 (es) | Compuesto, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular efectos de los receptores de histamina 3 | |
| RU2441869C2 (ru) | Противовирусные соединения | |
| ES2531660T3 (es) | Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio | |
| CO5690551A2 (es) | Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo | |
| PE20081897A1 (es) | 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas | |
| EA200971115A1 (ru) | Новые ингибиторы обратной транскриптазы вич | |
| AR127309A2 (es) | Derivados de piridazinona | |
| HUP0301094A2 (hu) | Kemonikinreceptorhoz kötżdż heterociklusos vegyületek, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
| PE20060691A1 (es) | Serinamidas sustituidas por benzoilo | |
| MX2009000871A (es) | Novedosos inhibidores de transcriptasa inversa de vih. | |
| AR061101A1 (es) | Compuesto de fenil-triazolil- metoxi- arilo, su uso para la manufactura de un medicamento y composicion farmaceutica que lo comprende | |
| EA200970047A1 (ru) | Водные суспензии тмс278 | |
| AR104915A1 (es) | Derivados de 2-(feniloxi o feniltio)pirimidina como herbicidas | |
| BRPI0410445A (pt) | inibidores de amida de ácido pirrolopiridina-2-carboxìlico de glicogênio fosforilase | |
| RU2010121763A (ru) | Производные пиридазинона и ингибиторы р2х7 рецептора | |
| NO20063329L (no) | Tricykliske steroidhormone nukleaer reseptormodulatorer | |
| CY1113341T1 (el) | Ρυθμιστες υποδοχεα ανδρογονου τετραϋδροκυκλοπεντα[β]ινδολιο | |
| WO2008132138A9 (en) | AMINOPYRIMIDINE DERIVATIVES DISUBSTITUTED IN 4 AND 6 | |
| EA201170456A1 (ru) | Синергические комбинации макроциклического ингибитора вируса гепатита с и нуклеозида | |
| AR060914A1 (es) | Derivados de furopiridina como ligandos receptores de la acetilcolina nicotinica, una composicion farmaceutica que los comprende y su empleo en la manufactura de un medicamento para el tratamiento de una enfermedad mediada por la activacion del receptor alfa7-nicotinico. | |
| AR085038A1 (es) | COMPUESTOS UTILES EN LA INHIBICION DE LA IL-17 Y DEL IFN-g PARA EL TRATAMIENTO DE LAS INFLAMACIONES AUTOINMUNES | |
| AR078536A1 (es) | Derivados de pirazol como ligandos del receptor de estrogeno | |
| AR073932A1 (es) | Compuestos de esteres de acido 2-(aminometiliden)-4,4-difluoro-3- oxobutirico y procedimiento para su preparacion | |
| ATE435223T1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate |